This volume gives an overview of state of the art technologies and future developments in the field of preclinical pharmaceutical research. A balanced mix of experts from academia and industry give insight in selected new developments in the drug discovery pathway. The topics cover the different parts of the drug discovery process, starting with new developments in the target identification and validation area. The lead generation part as a next step focuses on the requirements and technologies to identify new small molecules as lead compounds for further optimization; in a second section the technologies to identify biologics as leads are addressed. The final part focuses on the pharmacological models and technologies to characterize new compounds and the impact of biomarkers to facilitate the transfer of drug candidates into the development phase.
"synopsis" may belong to another edition of this title.
"About this title" may belong to another edition of this title.
Shipping:
£ 42.02
From Germany to U.S.A.
Book Description Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. In depth insights into drug discovery and early drug development Latest technologies of target discovery and lead generation   New approaches to transfer drug candidates to clinical development  Dr. Ulrich Nielsch, Ba. Seller Inventory # 106243215
Book Description Condition: New. Buy with confidence! Book is in new, never-used condition. Seller Inventory # bk3319289128xvz189zvxnew
Book Description Condition: New. New! This book is in the same immaculate condition as when it was published. Seller Inventory # 353-3319289128-new
Book Description Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume gives an overview ofstate of the art technologies and future developments in the field ofpreclinical pharmaceutical research. A balanced mix of experts from academiaand industry give insight in selected new developments in the drug discoverypathway. The topics cover the different parts of the drug discovery processstarting with new developments in the target identification and validationarea. The lead generation part as a next step focuses on the requirements andtechnologies to identify new small molecules as lead compounds for furtheroptimization; in a second section the technologies to identify biologics asleads are addressed. The final part focuses on the pharmacological models andtechnologies to characterize new compounds and the impact of biomarkers to facilitatethe transfer of drug candidates into the development phase. 352 pp. Englisch. Seller Inventory # 9783319289120
Book Description Gebundene Ausgabe. Condition: Neu. Neu neuware, auf lager - This volume gives an overview ofstate of the art technologies and future developments in the field of preclinical pharmaceutical research. A balanced mix of experts from academia and industry give insight in selected new developments in the drug discovery pathway. The topics cover the different parts of the drug discovery process, starting with new developments in the target identification and validation area. The lead generation part as a next step focuses on the requirements and technologies to identify new small molecules as lead compounds for further optimization; in a second section the technologies to identify biologics as leads are addressed. The final part focuses on the pharmacological models and technologies to characterize new compounds and the impact of biomarkers to facilitate the transfer of drug candidates into the development phase. 352 pp. Englisch. Seller Inventory # INF1000486443
Book Description Gebundene Ausgabe. Condition: Neu. Neu neuware, auf lager - This volume gives an overview ofstate of the art technologies and future developments in the field of preclinical pharmaceutical research. A balanced mix of experts from academia and industry give insight in selected new developments in the drug discovery pathway. The topics cover the different parts of the drug discovery process, starting with new developments in the target identification and validation area. The lead generation part as a next step focuses on the requirements and technologies to identify new small molecules as lead compounds for further optimization; in a second section the technologies to identify biologics as leads are addressed. The final part focuses on the pharmacological models and technologies to characterize new compounds and the impact of biomarkers to facilitate the transfer of drug candidates into the development phase. Seller Inventory # INF1000486443
Book Description Hardcover. Condition: Brand New. 1st edition. 341 pages. 9.25x6.25x1.00 inches. In Stock. Seller Inventory # zk3319289128
Book Description Hardcover. Condition: New. Seller Inventory # 6666-ING-9783319289120